| Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. | |
| | |
MedLine Citation:
|
PMID: 21854363 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
UDCA (ursodeoxycholic acid) is the therapeutic agent most widely used for the treatment of cholestatic hepatopathies. Its use has expanded to other kinds of hepatic diseases, and even to extrahepatic ones. Such versatility is the result of its multiple mechanisms of action. UDCA stabilizes plasma membranes against cytolysis by tensioactive bile acids accumulated in cholestasis. UDCA also halts apoptosis by preventing the formation of mitochondrial pores, membrane recruitment of death receptors and endoplasmic-reticulum stress. In addition, UDCA induces changes in the expression of metabolizing enzymes and transporters that reduce bile acid cytotoxicity and improve renal excretion. Its capability to positively modulate ductular bile flow helps to preserve the integrity of bile ducts. UDCA also prevents the endocytic internalization of canalicular transporters, a common feature in cholestasis. Finally, UDCA has immunomodulatory properties that limit the exacerbated immunological response occurring in autoimmune cholestatic diseases by counteracting the overexpression of MHC antigens and perhaps by limiting the production of cytokines by immunocompetent cells. Owing to this multi-functionality, it is difficult to envisage a substitute for UDCA that combines as many hepatoprotective effects with such efficacy. We predict a long-lasting use of UDCA as the therapeutic agent of choice in cholestasis. |
| | |
Authors:
|
Marcelo G Roma; Flavia D Toledo; Andrea C Boaglio; Cecilia L Basiglio; Fernando A Crocenzi; Enrique J Sánchez Pozzi |
Related Documents
:
|
22297663 - Synthesis of 5-alkylated barbituric acids and 3-alkylated indoles via microwave-assiste... 89053 - The production and control of anti--venous sera. 2293213 - In vitro skin absorption and metabolism of benzoic acid, p-aminobenzoic acid, and benzo... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Clinical science (London, England : 1979) Volume: 121 ISSN: 1470-8736 ISO Abbreviation: Clin. Sci. Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-08-22 Completed Date: 2011-10-17 Revised Date: 2011-10-20 |
Medline Journal Info:
|
Nlm Unique ID: 7905731 Medline TA: Clin Sci (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 523-44 Citation Subset: IM |
Affiliation:
|
Institute of Experimental Physiology (IFISE-CONICET), Faculty of Biochemical and Pharmacautical Sciences, National University of Rosario, Suipacha 570, S2002LRL Rosario, Argentina. mroma@fbioyf.unr.edu.ar |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Apoptosis / drug effects Bile Acids and Salts / physiology Bile Canaliculi / drug effects Cholagogues and Choleretics / pharmacology*, therapeutic use Cholestasis / drug therapy*, pathology, physiopathology Humans Immunologic Factors / pharmacology, therapeutic use Mitochondria, Liver / drug effects, metabolism Proto-Oncogene Proteins c-bcl-2 / metabolism Ursodeoxycholic Acid / pharmacology*, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Bile Acids and Salts; 0/Cholagogues and Choleretics; 0/Immunologic Factors; 0/Proto-Oncogene Proteins c-bcl-2; 128-13-2/Ursodeoxycholic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Application of Hyperthermia for Cancer Treatment: Recent Patents Review.
Next Document: Robot-assisted laparoscopic hysterectomy in obese and morbidly obese women. Surgical technique and c...